Good Lifestyle

Every day you do not infect yourself with Covid-19, buy experts to discover treatments that could save your life. In fact, a recent study of Canada, which has not yet been examined, has found that an anti-inflammatoryDrugs already on the market As a treatment of gout could significantly reduce the hospitalization and death rate in CVIV-19 cases. According to Montreal Heart Institute researchers, colchicine is administered orally and has little known side effects. Read more about this promising treatment and for other essential Covid news, checkIf you take these over-the-counter medes, you must stop before getting the vaccine.

The researchers gathered a group of covidant patients with a light disease and at least one underlying condition such as heart disease or diabetes. Half of the group received colchicine and the other half received a placebo for 30 days. In the end, they found that the risk of "death or hospitalization Due to COVID-19 infection within 30 days of randomization, patients were randomly assigned to receive colchicine than among those who received placebo. In addition, they reported that the treatment group had fewer cases of pneumonia and the need for additional oxygen.

The results were even more pronounced when they controlled subjects diagnosed with COVID via a PCR test. "When the 93% of patients who received a formal diagnosis of COVID-19 are considered, the benefit of colchicine [as defined by reduced rates ofHospitalization and death] was more marked (25%) and statistically significant, "wrote the researchers.

Although more research is needed, this could have major implications for people with underlying health conditions. "Since colchicine is inexpensive, taken by mouth, was generally safe in this study and does not generally need laboratory surveillance when using, it shows potential as the first oral medicine atCOVID-19 In the ambulatory setting, "said researchers. Not only would it be beneficial for the results of individual patients, he would also free hospital beds and retain resources for the most serious COVID cases.

Are you wondering what other medicines can improve your COVID result? Read more promising treatments currently under revision and for essential advice on Covid avoidance.These 3 things could prevent almost all cases of Covid, study.

According to a study published on December 21, which has not yet been examined by peers, researchers have found that aNasal spray on-the-counter known as Xlear Sinus care can helpNeutralize Covid in nasal cavities. Although the spray has only been done in vitro tests only, it has been able to significantly reduce the amount of Covid virus active after 25 minutes.

The ingredients of the sprayer comprise the xylitol-has often used as sweetening as well as grapefruit grape grain extract (Gse) and 0.85% saline solution. "The therapy combined with GSE and Xylitol can prevent the spread of viral respiratory infections not only for SARS-COV-2, but also for future H1N1 viral outbreaks or other viral epidemics. GSE considerably reduces viral load while the xylitol prevents the attachment of the virus on the base protein on the base wall protein, "the authors of the study wrote. And for more on what can reduce your risk of covidation, seeThese 3 vitamins could save you discoveries from the severe Covid study..

According to the Mayo Clinic, theThe FDA approved the Antiviral Drug Vedesivir Treat Covid-19 in adults and children aged 12 and over. Given intravenously, this drug is used to shorten the length of the infection in those who have been hospitalized with COVID-19.

The National Institute of Health (NIH) explains that the drug has "demonstratedIn vitro activity against Sars-Cov-2"And helped reduce the rate of pulmonary damage in COVID infected rhesus macaque monkeys. And for more cases of serious coronaviruses, checkIf you did that, you are twice as likely to develop severe covidation.

Monoclonal antibody treatments such as Regeneron's work by mimicy our own immune response to a threat of Covid. According to BBC News, "Antibodies physically stick to coronaviruses So, they can not enter the cells of the body and they make the virus more "visible" to the rest of the immune system ".

While Regeneron was one of the oldest approved treatments to combat existing Covid cases, researchers have recently discovered thatThe drug can work preventively-sensebeforeIndividuals are exposed to the new coronavirus. In a new study conducted by Uva Health, the researchers found that when 186 people received theantibody cocktail And then exposed to Covid, no symptomatic cases developed by COVID. While Regeneron is unlikely to provide long-term preventive protection, it could be beneficial for those who face high risks of infection for a short period of time - for example, a person who deals with a infected parent. And for more COVID news, delivered directly to your inbox,Sign up for our daily newsletter.

New research shows that those who takeA daily dose of aspirin Can feel better covidant results than those who do not. An October study published in the journalAnesthesia and Analgesia I looked at the medical records of more than 400 hospitalized coronavirus patients from March to July following the virus. They found that more than 23% of thesePatients took a low daily dose of aspirin Shortly before or soon after being admitted to the hospital to manage cardiovascular disease.

Among the hospitalized covid patients, those who have taken a low daily aspirin dose were 43% less likely to be put in the intensive care unit (ICU) and 44% less likely to be placed on a fan . These same patients were also less than 47% less likely to die from COVID than hospitalized patients who did not take aspirin daily. And to avoid contracting Covid in the first place, beware thatThis is where you are most likely to catch Covid now, a new study says.